{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:15:04Z","timestamp":1771668904842,"version":"3.50.1"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Significant progress has been achieved in the management of multiple myeloma (MM) by implementing high-dose therapy and stem cell transplantation. Moreover, the prognosis of patients has been enhanced due to the introduction of novel immunomodulatory drugs and the emergence of new targeted therapies. However, predicting the survival rates of patients with multiple myeloma is still tricky. According to recent researches, platelets have a significant impact in affecting the biological activity of tumors and are essential parts of the tumor microenvironment. Nonetheless, it is still unclear how platelet-related genes (PRGs) connect to the prognosis of multiple myeloma.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We analyzed the expression of platelet-related genes and their prognostic value in multiple myeloma patients in this study. We also created a nomogram combining clinical metrics. Furthermore, we investigated disparities in the biological characteristics, immunological microenvironment, and reaction to immunotherapy, along with analyzing the drug susceptibility within diverse risk groups.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> By using the platelet-related risk model, we were able to predict patients\u2019 prognosis more accurately. Subjects in the high-risk cohort exhibited inferior survival outcomes, both in the training and validation datasets, as compared to those in the low-risk cohort (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). Moreover, there were differences in the immunological microenvironments, biological processes, clinical features, and chemotherapeutic drug sensitivity between the groups at high and low risk. Using multivariable Cox regression analyses, platelet-related risk score was shown to be an independent prognostic influence in MM (<jats:italic>p<\/jats:italic> &amp;lt; 0.001, hazard ratio (HR) = 2.001%, 95% confidence interval (CI): 1.467\u20132.730). Furthermore, the capacity to predict survival was further improved when a combined nomogram was utilized. In training cohort, this outperformed the predictive value of International staging system (ISS) alone from a 5-years area under curve (AUC) = 0.668 (95% CI: 0.611\u20130.725) to an AUC = 0.721 (95% CI: 0.665\u20130.778).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our study revealed the potential benefits of PRGs in terms of survival prognosis of MM patients. Furthermore, we verified its potential as a drug target for MM patients. These findings open up novel possibilities for prognostic evaluation and treatment choices for MM.<\/jats:p>","DOI":"10.3389\/fphar.2024.1377370","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T04:54:00Z","timestamp":1715835240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhili","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enqing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouxiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songfu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-368050","article-title":"P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment","volume":"119","author":"Abdel Kareem","year":"2011","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/ijms18030487","article-title":"Pancreatic cancer-induced neutrophil extracellular traps: a potential contributor to cancer-associated thrombosis","volume":"18","author":"Abdol Razak","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B3","first-page":"14","article-title":"Role of cytokines in multiple myeloma","volume":"36","author":"Anderson","year":"1999","journal-title":"Seminars Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1191009","DOI":"10.3389\/fonc.2023.1191009","article-title":"Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer","volume":"13","author":"Bai","year":"2023","journal-title":"Front. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3324\/haematol.2017.178103","article-title":"Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry","volume":"103","author":"Blimark","year":"2018","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12885-015-1350-6","article-title":"Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer","volume":"15","author":"Bondarenko","year":"2015","journal-title":"BMC cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41375-021-01506-9","article-title":"Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients","volume":"36","author":"Caro","year":"2022","journal-title":"Leukemia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1158\/1078-0432.Ccr-06-2971","article-title":"Hypoxia and metastasis","volume":"13","author":"Chaudary","year":"2007","journal-title":"Clin. cancer Res. official J. Am. Assoc. Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/jth.14730","article-title":"Structure and function of the ubiquitin-proteasome system in platelets","volume":"18","author":"Colberg","year":"2020","journal-title":"J. thrombosis haemostasis JTH"},{"key":"B12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1182\/blood-2017-04-780825","article-title":"Platelet interaction with activated endothelium: mechanistic insights from microfluidics","volume":"130","author":"Dani\u00ebLLE","year":"2017","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1060361","DOI":"10.3389\/fmolb.2022.1060361","article-title":"Filamin A in platelets: bridging the (signaling) gap between the plasma membrane and the actin cytoskeleton","volume":"9","author":"de Silva","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/09537104.2013.805405","article-title":"Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients","volume":"25","author":"Dorota","year":"2013","journal-title":"Platelets"},{"key":"B16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.crstbi.2021.10.001","article-title":"Role of actin cytoskeleton in the organization and function of ionotropic glutamate receptors","volume":"3","author":"Dutta","year":"2021","journal-title":"Curr. Res. Struct. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1182\/blood.2023021292","article-title":"GPIb\u03b1-filamin A interaction regulates megakaryocyte localization and budding during platelet biogenesis","volume":"143","author":"Ellis","year":"2024","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.apsb.2021.09.010","article-title":"The generation of PD-L1 and PD-L2 in cancer cells: from nuclear chromatin reorganization to extracellular presentation","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41525-018-0054-7","article-title":"Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples","volume":"3","author":"Givechian","year":"2018","journal-title":"NPJ genomic Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e29312","DOI":"10.1097\/md.0000000000029312","article-title":"KIF23 is a potential biomarker of diffuse large B cell lymphoma: analysis based on bioinformatics and immunohistochemistry","volume":"101","author":"Gong","year":"2022","journal-title":"Medicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"642761","DOI":"10.3389\/fonc.2021.642761","article-title":"The role of platelet cell surface P-selectin for the direct platelet-tumor cell contact during metastasis formation in human tumors","volume":"11","author":"Hans-\u00c5ke","year":"2021","journal-title":"Front. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/bjc.2013.806","article-title":"Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours","volume":"110","author":"Hoh","year":"2014","journal-title":"Br. J. cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1101\/gad.349431.122","article-title":"DNA repair defects in cancer and therapeutic opportunities","volume":"36","author":"Hopkins","year":"2022","journal-title":"Genes. & Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/1440-1681.13718","article-title":"KIF23 promotes autophagy-induced imatinib resistance in chronic myeloid leukaemia through activating Wnt\/\u03b2-catenin pathway","volume":"49","author":"Huang","year":"2022","journal-title":"Clin. Exp. Pharmacol. physiology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","article-title":"Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA","volume":"41","author":"Jin","year":"2022","journal-title":"J. Exp. Clin. cancer Res. CR"},{"key":"B27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5694\/j.1326-5377.2005.tb07079.x","article-title":"Multiple myeloma: the present and the future","volume":"183","author":"Joshua","year":"2005","journal-title":"Med. J. Aust."},{"key":"B28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5694\/mja2.50129","article-title":"Biology and therapy of multiple myeloma","volume":"210","author":"Joshua","year":"2019","journal-title":"Med. J. Aust."},{"key":"B29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1053\/j.seminhematol.2012.04.010","article-title":"Bortezomib combination therapy in multiple myeloma","volume":"49","author":"Kapoor","year":"2012","journal-title":"Seminars Hematol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"Keats","year":"2012","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.4110\/in.2020.20.e4","article-title":"Regulatory T cells in tumor microenvironment and approach for anticancer immunotherapy","volume":"20","author":"Kim","year":"2020","journal-title":"Immune Netw."},{"key":"B32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/cyto.2001.0982","article-title":"Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data","volume":"16","author":"Lauta","year":"2001","journal-title":"Cytokine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"939089","DOI":"10.3389\/fonc.2022.939089","article-title":"Emerging roles of platelets in cancer biology and their potential as therapeutic targets","volume":"12","author":"Lei","year":"2022","journal-title":"Front. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/09537104.2013.805405","article-title":"Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients","volume":"25","author":"Lemancewicz","year":"2014","journal-title":"Platelets"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1002\/mco2.350","article-title":"The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy","volume":"4","author":"Liao","year":"2023","journal-title":"MedComm"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.3109\/10428194.2014.897700","article-title":"Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups","volume":"55","author":"Libby","year":"2014","journal-title":"Leukemia lymphoma"},{"key":"B37","doi-asserted-by":"publisher","first-page":"eadf3924","DOI":"10.1126\/sciadv.adf3924","article-title":"Cathepsin W restrains peripheral regulatory T cells for mucosal immune quiescence","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"919495","DOI":"10.3389\/fcvm.2022.919495","article-title":"Patients with multiple myeloma have a disbalanced whole blood thrombin generation profile","volume":"9","author":"Li","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1758835919849757","DOI":"10.1177\/1758835919849757","article-title":"Axitinib overcomes multiple imatinib resistant cKIT mutations including the gatekeeper mutation T670I in gastrointestinal stromal tumors","volume":"11","author":"Liu","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","article-title":"Cell cycle on the crossroad of tumorigenesis and cancer therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Trends Cell. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12967-024-05104-y","article-title":"Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bjh.18295","article-title":"Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review","volume":"199","author":"Mccaughan","year":"2022","journal-title":"Br. J. Haematol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e612","DOI":"10.1038\/bcj.2017.94","article-title":"High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma","volume":"7","author":"Miller","year":"2017","journal-title":"Blood cancer J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2014.11.001","article-title":"Targeting the TGF\u03b2 pathway for cancer therapy","volume":"147","author":"Neuzillet","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. methods"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.7150\/jca.84454","article-title":"An integrated analysis identified TAGLN2 as an oncogene indicator related to prognosis and immunity in pan-cancer","volume":"14","author":"Pan","year":"2023","journal-title":"J. Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s12276-021-00576-0","article-title":"Function of \u03b3\u03b4 T cells in tumor immunology and their application to cancer therapy","volume":"53","author":"Park","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers13020226","article-title":"Alterations of NK cell phenotype in the disease course of multiple myeloma","volume":"13","author":"Pazina","year":"2021","journal-title":"Cancers"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"eLife"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1182\/blood.2019000014","article-title":"Filamin A: key actor in platelet biology","volume":"134","author":"Rosa","year":"2019","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1517\/14712598.2013.799130","article-title":"Immunologic microenvironment and personalized treatment in multiple myeloma","author":"Rossi","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-2004-822974","article-title":"Platelets and angiogenesis in malignancy","volume":"30","author":"Sierko","year":"2004","journal-title":"Seminars thrombosis hemostasis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"727987","DOI":"10.3389\/fmed.2021.727987","article-title":"SOCS proteins in immunity, inflammatory diseases, and immune-related cancer","volume":"8","author":"Sobah","year":"2021","journal-title":"Front. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/s0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet London, Engl."},{"key":"B58","doi-asserted-by":"publisher","first-page":"939089","DOI":"10.3389\/fonc.2022.939089","article-title":"Emerging roles of platelets in cancer biology and their potential as therapeutic targets","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"909767","DOI":"10.3389\/fonc.2022.909767","article-title":"Tumor cell-induced platelet aggregation as an emerging therapeutic target for cancer therapy","volume":"12","author":"Wiktoria","year":"2022","journal-title":"Front. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e12072","DOI":"10.1016\/j.heliyon.2022.e12072","article-title":"Roles of platelets in tumor invasion and metastasis: a review","volume":"8","author":"Xiulan","year":"2022","journal-title":"Heliyon"},{"key":"B61","doi-asserted-by":"publisher","first-page":"341430","DOI":"10.1155\/2015\/341430","article-title":"Mechanisms of drug resistance in relapse and refractory multiple myeloma","volume":"2015","author":"Yang","year":"2015","journal-title":"BioMed Res. Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","volume":"14","author":"Yi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3892\/ol.2021.12998","article-title":"TAGLN2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells by activating STAT3 signaling through ANXA2","volume":"22","author":"Zhao","year":"2021","journal-title":"Oncol. Lett."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1377370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T04:54:03Z","timestamp":1715835243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1377370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":63,"alternative-id":["10.3389\/fphar.2024.1377370"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1377370","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"article-number":"1377370"}}